Tapewire

Nasdaq · USD

FBLG

FibroBiologics, Inc.

Export transactions ↓
Tapewire entity
7875
SEC CIK
0001958777
Parsed reports
57

Last 12 months

Inside the activity.

7 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202510
Jan 202600
Feb 202610
Mar 202650
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 15, 2026 Filed Sep 15, 2026 23:26 UTC
Khoja HamidChief Scientific Officer
GrantWarrant (Right to Buy) · Derivative 298,508 Not disclosed Strike: $1.55 Not disclosed
Disclosure

SEC source: 0001493152-26-042794 · ownership.xml · derivative · entry 2

Khoja Hamid · CIK 0002010662 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 298,508

Underlying: Common Stock · 298,508 shares

Expires 2031-09-15

F1 · kind: On September 15, 2026, the reporting person entered into a securities purchase agreement with FibroBiologics, Inc. (the "Company") to purchase 298,508 shares of the Company's common stock, par value $0.00001 per share (the "Common Stock"), and accompanying warrants to purchase up to 298,508 shares of Common Stock (the "Warrants"), in a private placement (the "Offering").

F2 · price: Each share of Common Stock and accompanying Warrant were issued at a combined purchase price of $1.675.

F3 · derivative.exercise_date: The warrants are exercisable at any time until they expire.

Read SEC document
September 15, 2026 Filed Sep 15, 2026 23:26 UTC
Khoja HamidChief Scientific Officer
GrantCommon Stock 298,508 $1.68 $500,000.90
Disclosure

SEC source: 0001493152-26-042794 · ownership.xml · nonDerivative · entry 1

Khoja Hamid · CIK 0002010662 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 301,571

F1 · kind: On September 15, 2026, the reporting person entered into a securities purchase agreement with FibroBiologics, Inc. (the "Company") to purchase 298,508 shares of the Company's common stock, par value $0.00001 per share (the "Common Stock"), and accompanying warrants to purchase up to 298,508 shares of Common Stock (the "Warrants"), in a private placement (the "Offering").

F2 · price: Each share of Common Stock and accompanying Warrant were issued at a combined purchase price of $1.675.

Read SEC document
June 23, 2026 Filed Jun 24, 2026 00:02 UTC GrantStock Option (Right to Buy) · Derivative 30,803 $0.00 Strike: $0.75 $0.00
Disclosure

SEC source: 0001493152-26-029851 · ownership.xml · derivative · entry 1

Hoffman Robert E. · CIK 0001166288 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,803

Underlying: Common Stock · 30,803 shares

Expires 2036-06-22

F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.

Read SEC document
June 23, 2026 Filed Jun 23, 2026 23:59 UTC GrantStock Option (Right to Buy) · Derivative 30,803 $0.00 Strike: $0.75 $0.00
Disclosure

SEC source: 0001493152-26-029848 · ownership.xml · derivative · entry 1

Niklas Victoria Ninon Olivia · CIK 0002012250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,803

Underlying: Common Stock · 30,803 shares

Expires 2036-06-22

F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.

Read SEC document
June 23, 2026 Filed Jun 24, 2026 00:00 UTC
Link MatthewDirector
GrantStock Option (Right to Buy) · Derivative 30,803 $0.00 Strike: $0.75 $0.00
Disclosure

SEC source: 0001493152-26-029849 · ownership.xml · derivative · entry 1

Link Matthew · CIK 0001565950 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,803

Underlying: Common Stock · 30,803 shares

Expires 2036-06-22

F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.

Read SEC document
June 23, 2026 Filed Jun 24, 2026 00:01 UTC GrantStock Option (Right to Buy) · Derivative 30,803 $0.00 Strike: $0.75 $0.00
Disclosure

SEC source: 0001493152-26-029850 · ownership.xml · derivative · entry 1

Cilento Richard C. Jr. · CIK 0002010661 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,803

Underlying: Common Stock · 30,803 shares

Expires 2036-06-22

F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.

Read SEC document
May 04, 2026 Filed May 4, 2026 23:00 UTC
GARCIA RUBEN AGeneral Counsel
GrantStock Option (Right to Buy) · Derivative 61,607 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001493152-26-021172 · ownership.xml · derivative · entry 1

GARCIA RUBEN A · CIK 0002013617 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,607

Underlying: Common Stock · 61,607 shares

Expires 2036-05-04

F1 · derivative.exercise_date: On May 4, 2026, the reporting person was granted an option to purchase 61,607 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document
May 04, 2026 Filed May 4, 2026 23:00 UTC
Davis JasonChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 61,607 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001493152-26-021173 · ownership.xml · derivative · entry 1

Davis Jason · CIK 0001443533 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,607

Underlying: Common Stock · 61,607 shares

Expires 2036-05-04

F1 · derivative.exercise_date: On May 4, 2026, the reporting person was granted an option to purchase 61,607 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document
May 04, 2026 Filed May 4, 2026 23:01 UTC
O'HEERON PETEDirector · CHIEF EXECUTIVE OFFICER
GrantStock Option (Right to Buy) · Derivative 92,410 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001493152-26-021175 · ownership.xml · derivative · entry 1

O'HEERON PETE · CIK 0001569334 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,410

Underlying: Common Stock · 92,410 shares

Expires 2036-05-04

F1 · derivative.exercise_date: On May 4, 2026, the reporting person was granted an option to purchase 92,410 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document
May 04, 2026 Filed May 4, 2026 23:00 UTC
Khoja HamidChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 61,607 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001493152-26-021174 · ownership.xml · derivative · entry 1

Khoja Hamid · CIK 0002010662 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,607

Underlying: Common Stock · 61,607 shares

Expires 2036-05-04

F1 · derivative.exercise_date: On May 4, 2026, the reporting person was granted an option to purchase 61,607 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods

Read SEC document
March 04, 2026 Filed Mar 4, 2026 22:50 UTC
O'HEERON PETEDirector · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 15,872 $0.38 $6,005.96
Disclosure

SEC source: 0001493152-26-008903 · ownership.xml · nonDerivative · entry 3

O'HEERON PETE · CIK 0001569334 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,958,147

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3210 to $0.4166 on March 2, 2026, $0.3885 to $0.4302 on March 3, 2026, and $0.3730 to $0.3820 on March 4, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 13:00 UTC
Khoja HamidChief Scientific Officer
PurchaseCommon Stock 30,000 $0.38 $11,400.00
Disclosure

SEC source: 0001493152-26-008933 · ownership.xml · nonDerivative · entry 1

Khoja Hamid · CIK 0002010662 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,250

Read SEC document
March 03, 2026 Filed Mar 4, 2026 22:50 UTC
O'HEERON PETEDirector · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 18,200 $0.41 $7,372.82
Disclosure

SEC source: 0001493152-26-008903 · ownership.xml · nonDerivative · entry 2

O'HEERON PETE · CIK 0001569334 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,942,275

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3210 to $0.4166 on March 2, 2026, $0.3885 to $0.4302 on March 3, 2026, and $0.3730 to $0.3820 on March 4, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 13:00 UTC
Davis JasonChief Financial Officer
PurchaseCommon Stock 70,000 $0.41 $28,973.00
Disclosure

SEC source: 0001493152-26-008646 · ownership.xml · nonDerivative · entry 1

Davis Jason · CIK 0001443533 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3968 to $0.4200 on March 2, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 22:50 UTC
O'HEERON PETEDirector · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 17,428 $0.35 $6,152.08
Disclosure

SEC source: 0001493152-26-008903 · ownership.xml · nonDerivative · entry 1

O'HEERON PETE · CIK 0001569334 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,924,075

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3210 to $0.4166 on March 2, 2026, $0.3885 to $0.4302 on March 3, 2026, and $0.3730 to $0.3820 on March 4, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
February 27, 2026 Filed Mar 2, 2026 14:15 UTC
GARCIA RUBEN AGeneral Counsel
PurchaseCommon Stock 40,000 $0.33 $13,056.00
Disclosure

SEC source: 0001493152-26-008469 · ownership.xml · nonDerivative · entry 1

GARCIA RUBEN A · CIK 0002013617 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3221 to $0.3268 on February 27, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
December 11, 2025 Filed Dec 12, 2025 12:16 UTC
GARCIA RUBEN AGeneral Counsel
PurchaseCommon Stock 140,000 $0.34 $47,600.00
Disclosure

SEC source: 0001493152-25-027363 · ownership.xml · nonDerivative · entry 1

GARCIA RUBEN A · CIK 0002013617 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3333 to $0.3504 on December 11, 2025. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
June 12, 2025 Filed Jun 12, 2025 23:23 UTC GrantStock Option (Right to Buy) · Derivative 22,000 $0.00 Strike: $0.87 $0.00
Disclosure

SEC source: 0001641172-25-014934 · ownership.xml · derivative · entry 1

Hoffman Robert E. · CIK 0001166288 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires 2025-06-11

F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.

Read SEC document
June 12, 2025 Filed Jun 12, 2025 23:30 UTC GrantStock Option (Right to Buy) · Derivative 22,000 $0.00 Strike: $0.87 $0.00
Disclosure

SEC source: 0001641172-25-014941 · ownership.xml · derivative · entry 1

Niklas Victoria Ninon Olivia · CIK 0002012250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires 2025-06-11

F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.

Read SEC document
June 12, 2025 Filed Jun 12, 2025 19:20 UTC GrantStock Option (Right to Buy) · Derivative 22,000 $0.00 Strike: $0.87 $0.00
Disclosure

SEC source: 0001641172-25-014931 · ownership.xml · derivative · entry 1

Coen Stacy Ann · CIK 0001814150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires 2025-06-11

F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.

Read SEC document
June 12, 2025 Filed Jun 12, 2025 23:26 UTC
Link MatthewDirector
GrantStock Option (Right to Buy) · Derivative 22,000 $0.00 Strike: $0.87 $0.00
Disclosure

SEC source: 0001641172-25-014939 · ownership.xml · derivative · entry 1

Link Matthew · CIK 0001565950 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires 2025-06-11

F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.

Read SEC document
June 12, 2025 Filed Jun 12, 2025 23:16 UTC GrantStock Option (Right to Buy) · Derivative 22,000 $0.00 Strike: $0.87 $0.00
Disclosure

SEC source: 0001641172-25-014927 · ownership.xml · derivative · entry 1

Cilento Richard C. Jr. · CIK 0002010661 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.

Read SEC document
June 09, 2025 Filed Jun 10, 2025 20:03 UTC
Davis JasonChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 450,000 $0.00 Strike: $0.94 $0.00
Disclosure

SEC source: 0001641172-25-014512 · ownership.xml · derivative · entry 1

Davis Jason · CIK 0001443533 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Stock · 450,000 shares

Expires 2035-06-08

F1 · derivative.exercise_date: On June 9, 2025, the reporting person was granted an option to purchase 450,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document
May 27, 2025 Filed May 27, 2025 21:56 UTC
Khoja HamidChief Scientific Officer
PurchaseCommon Stock 20,000 $0.84 $16,800.00
Disclosure

SEC source: 0001641172-25-012539 · ownership.xml · nonDerivative · entry 1

Khoja Hamid · CIK 0002010662 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,250

Read SEC document
March 26, 2025 Filed Mar 28, 2025 20:10 UTC
GARCIA RUBEN AGeneral Counsel
GrantStock Option (Right to Buy) · Derivative 189,000 $0.00 Strike: $1.04 $0.00
Disclosure

SEC source: 0001641172-25-001188 · ownership.xml · derivative · entry 1

GARCIA RUBEN A · CIK 0002013617 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,000

Underlying: Common Stock · 189,000 shares

Expires 2035-03-25

F1 · derivative.exercise_date: On March 26, 2025, the reporting person was granted an option to purchase 189,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document
March 26, 2025 Filed Mar 28, 2025 20:10 UTC
O'HEERON PETEDirector · CHIEF EXECUTIVE OFFICER
GrantStock Option (Right to Buy) · Derivative 453,000 $0.00 Strike: $1.04 $0.00
Disclosure

SEC source: 0001641172-25-001189 · ownership.xml · derivative · entry 1

O'HEERON PETE · CIK 0001569334 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 453,000

Underlying: Common Stock · 453,000 shares

Expires 2035-03-25

F1 · derivative.exercise_date: On March 26, 2025, the reporting person was granted an option to purchase 453,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document
March 26, 2025 Filed Mar 28, 2025 20:10 UTC
Khoja HamidCHIEF SCIENTIFIC OFFICER
GrantStock Option (Right to Buy) · Derivative 189,000 $0.00 Strike: $1.04 $0.00
Disclosure

SEC source: 0001641172-25-001187 · ownership.xml · derivative · entry 1

Khoja Hamid · CIK 0002010662 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,000

Underlying: Common Stock · 189,000 shares

Expires 2035-03-25

F1 · derivative.exercise_date: On March 26, 2025, the reporting person was granted an option to purchase 189,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document
December 27, 2024 Filed Dec 30, 2024 21:18 UTC
GARCIA RUBEN AGeneral Counsel
GrantStock Option (Right to Buy) · Derivative 176,200 $0.00 Strike: $2.36 $0.00
Disclosure

SEC source: 0001493152-24-052488 · ownership.xml · derivative · entry 1

GARCIA RUBEN A · CIK 0002013617 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,200

Underlying: Common Stock · 176,200 shares

Expires 2034-12-26

F1 · derivative.exercise_date: On December 27, 2024, the reporting person was granted an option to purchase 176,200 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document
December 27, 2024 Filed Dec 30, 2024 21:21 UTC
O'HEERON PETEDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 406,339 $0.00 Strike: $2.36 $0.00
Disclosure

SEC source: 0001493152-24-052493 · ownership.xml · derivative · entry 1

O'HEERON PETE · CIK 0001569334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 406,339

Underlying: Common Stock · 406,339 shares

Expires 2034-12-26

F1 · derivative.exercise_date: On December 27, 2024, the reporting person was granted an option to purchase 406,339 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document
December 27, 2024 Filed Dec 30, 2024 21:20 UTC
Khoja HamidCHIEF SCIENTIFIC OFFICER
GrantStock Option (Right to Buy) · Derivative 176,200 $0.00 Strike: $2.36 $0.00
Disclosure

SEC source: 0001493152-24-052490 · ownership.xml · derivative · entry 1

Khoja Hamid · CIK 0002010662 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,200

Underlying: Common Stock · 176,200 shares

Expires 2034-12-26

F1 · derivative.exercise_date: On December 27, 2024, the reporting person was granted an option to purchase 176,200 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document
December 09, 2024 Filed Dec 10, 2024 02:33 UTC
O'HEERON PETEDirector · Chief Executive Officer
GiftCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-049341 · ownership.xml · nonDerivative · entry 1

O'HEERON PETE · CIK 0001569334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,906,647

Read SEC document
December 03, 2024 Filed Dec 5, 2024 22:58 UTC
O'HEERON PETEDirector · Chief Executive Officer
GiftCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-048916 · ownership.xml · nonDerivative · entry 1

O'HEERON PETE · CIK 0001569334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,006,647

Read SEC document
August 27, 2024 Filed Aug 27, 2024 23:53 UTC GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001493152-24-034068 · ownership.xml · derivative · entry 1

Hoffman Robert E. · CIK 0001166288 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2034-08-26

F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.

Read SEC document
August 27, 2024 Filed Aug 27, 2024 23:55 UTC GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001493152-24-034072 · ownership.xml · derivative · entry 1

Niklas Victoria Ninon Olivia · CIK 0002012250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2034-08-26

F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.

Read SEC document
August 27, 2024 Filed Aug 27, 2024 19:51 UTC GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001493152-24-034066 · ownership.xml · derivative · entry 1

Coen Stacy Ann · CIK 0001814150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2034-08-26

F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.

Read SEC document
August 27, 2024 Filed Aug 27, 2024 23:54 UTC
Link MatthewDirector
GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001493152-24-034070 · ownership.xml · derivative · entry 1

Link Matthew · CIK 0001565950 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2034-08-26

F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.

Read SEC document
August 27, 2024 Filed Aug 27, 2024 23:47 UTC GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001493152-24-034064 · ownership.xml · derivative · entry 1

Cilento Richard C. Jr. · CIK 0002010661 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2034-08-26

F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.

Read SEC document
August 12, 2024 Filed Aug 13, 2024 01:58 UTC
O'HEERON PETEDirector · Chief Executive Officer
PurchaseCommon Stock 8,500 $1.91 $16,269.00
Disclosure

SEC source: 0001493152-24-031439 · ownership.xml · nonDerivative · entry 1

O'HEERON PETE · CIK 0001569334 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,056,647

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiples transactions ranging from $1.82 to $2.017 on August 12, 2024. The reporting person will provide upon request to the SEC, the issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
August 12, 2024 Filed Aug 13, 2024 01:58 UTC
Khoja HamidChief Scientific Officer
PurchaseCommon Stock 10,000 $1.90 $19,000.00
Disclosure

SEC source: 0001493152-24-031438 · ownership.xml · nonDerivative · entry 1

Khoja Hamid · CIK 0002010662 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,250

Read SEC document
March 01, 2024 Filed Mar 8, 2024 21:14 UTC
GARCIA RUBEN AGeneral Counsel
GrantStock Option (Right to Buy) · Derivative 180,000 $0.00 Strike: $13.00 $0.00
Disclosure

SEC source: 0001493152-24-009398 · ownership.xml · derivative · entry 1

GARCIA RUBEN A · CIK 0002013617 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common Stock · 180,000 shares

Expires 2034-02-28

F1 · derivative.exercise_date: On March 1, 2024, the reporting person was granted an option to purchase 180,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.